Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Haen

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996
The effect of cyclosporin A and FK 506 on the cAMP content in psoriatic keratinocytesH M Ockenfels, G Nussbaum, B Schneck, et al.
Pharmacopsychiatry|March 20, 2012
The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditionsS Unterecker, C Hiemke, C Greiner, et al.
MMW Fortschritte Der Medizin|February 25, 2005
[Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]H J Möller, M Bauer, J Fritze, et al.
Chest|November 1, 1991
Nocturnal asthma. Beta 2-adrenoceptors on peripheral mononuclear leukocytes, cAMP- and cortisol-plasma concentrationsE Haen, R Hauck, H P Emslander, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 27, 2014
Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMIH P Sigurdsson, G Hefner, N Ben-Omar, et al.
Pharmacopsychiatry|February 6, 2015
Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepinesL Wolf, A Bauer, D Melchner, et al.
Pharmacopsychiatry|October 5, 2011
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|November 5, 2011
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|February 2, 2018
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pharmacopsychiatry|September 15, 2017
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996
The effect of cyclosporin A and FK 506 on the cAMP content in psoriatic keratinocytesH M Ockenfels, G Nussbaum, B Schneck, et al.
Pharmacopsychiatry|March 20, 2012
The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditionsS Unterecker, C Hiemke, C Greiner, et al.
MMW Fortschritte Der Medizin|February 25, 2005
[Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?]H J Möller, M Bauer, J Fritze, et al.
Chest|November 1, 1991
Nocturnal asthma. Beta 2-adrenoceptors on peripheral mononuclear leukocytes, cAMP- and cortisol-plasma concentrationsE Haen, R Hauck, H P Emslander, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|September 27, 2014
Steady-state serum concentrations of venlafaxine in patients with late-life depression. Impact of age, sex and BMIH P Sigurdsson, G Hefner, N Ben-Omar, et al.
Pharmacopsychiatry|February 6, 2015
Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepinesL Wolf, A Bauer, D Melchner, et al.
Pharmacopsychiatry|October 5, 2011
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|November 5, 2011
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|February 2, 2018
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pharmacopsychiatry|September 15, 2017
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pageof 5